HEADER TRANSFERASE 14-AUG-20 7CSJ TITLE AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE FROM MYCOLICIBACTERIUM TITLE 2 SMEGMATIS-COMPLEX WITH COENZYME A AND GENTAMICIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMINOGLYCOSIDE 2'-N-ACETYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AAC(2')-ID; COMPND 5 EC: 2.3.1.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOLICIBACTERIUM SMEGMATIS (STRAIN ATCC 700084 SOURCE 3 / MC(2)155); SOURCE 4 ORGANISM_TAXID: 246196; SOURCE 5 GENE: AAC, MSMEG_0434, MSMEI_0423; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS AMINOGLYCOSIDE ACETYLTRANSFERASE, ANTIBIOTICS, GENTAMICIN, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.S.JEONG,J.HWANG,H.DO,J.H.LEE REVDAT 2 29-NOV-23 7CSJ 1 REMARK REVDAT 1 23-JUN-21 7CSJ 0 JRNL AUTH C.S.JEONG,J.HWANG,H.DO,S.S.CHA,T.J.OH,H.J.KIM,H.H.PARK, JRNL AUTH 2 J.H.LEE JRNL TITL STRUCTURAL AND BIOCHEMICAL ANALYSES OF AN AMINOGLYCOSIDE JRNL TITL 2 2'-N-ACETYLTRANSFERASE FROM MYCOLICIBACTERIUM SMEGMATIS. JRNL REF SCI REP V. 10 21503 2020 JRNL REFN ESSN 2045-2322 JRNL PMID 33299080 JRNL DOI 10.1038/S41598-020-78699-Z REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.95 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 20629 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 1005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 4.1463 - 3.2914 0.99 2848 140 0.1819 0.2422 REMARK 3 2 3.2914 - 2.8755 0.99 2785 171 0.2222 0.2753 REMARK 3 3 2.8755 - 2.6126 0.98 2796 143 0.2353 0.3225 REMARK 3 4 2.6126 - 2.4254 0.98 2785 135 0.2319 0.2758 REMARK 3 5 2.4254 - 2.2824 0.97 2736 140 0.2299 0.3016 REMARK 3 6 2.2824 - 2.1681 0.95 2676 118 0.2341 0.3186 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.016 3061 REMARK 3 ANGLE : 1.331 4184 REMARK 3 CHIRALITY : 0.106 463 REMARK 3 PLANARITY : 0.006 532 REMARK 3 DIHEDRAL : 7.017 1772 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7CSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1300018175. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-OCT-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20679 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.168 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 37.9850 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.32500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.460 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 7CRM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM CITRATE: CITRIC ACID (PH REMARK 280 5.5), 20% (W/V) PEG 3000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.24300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.47750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.10600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.47750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.24300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 30.10600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LEU A 2 REMARK 465 THR A 3 REMARK 465 GLN A 4 REMARK 465 HIS A 5 REMARK 465 VAL A 6 REMARK 465 SER A 7 REMARK 465 GLU A 8 REMARK 465 ALA A 9 REMARK 465 ARG A 10 REMARK 465 THR A 11 REMARK 465 ARG A 12 REMARK 465 GLY A 13 REMARK 465 ALA A 14 REMARK 465 SER A 46 REMARK 465 GLY A 47 REMARK 465 ASP A 48 REMARK 465 SER A 49 REMARK 465 ASP A 50 REMARK 465 PHE A 51 REMARK 465 THR A 52 REMARK 465 MET B 1 REMARK 465 LEU B 2 REMARK 465 THR B 3 REMARK 465 GLN B 4 REMARK 465 HIS B 5 REMARK 465 VAL B 6 REMARK 465 SER B 7 REMARK 465 GLU B 8 REMARK 465 ALA B 9 REMARK 465 ARG B 10 REMARK 465 THR B 11 REMARK 465 ARG B 12 REMARK 465 GLY B 13 REMARK 465 ALA B 14 REMARK 465 ILE B 15 REMARK 465 ASP B 44 REMARK 465 PRO B 45 REMARK 465 SER B 46 REMARK 465 GLY B 47 REMARK 465 ASP B 48 REMARK 465 SER B 49 REMARK 465 ASP B 50 REMARK 465 PHE B 51 REMARK 465 THR B 52 REMARK 465 ASP B 53 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 96 -84.55 -64.67 REMARK 500 ASP A 187 60.49 -154.76 REMARK 500 ASP A 190 -84.19 12.65 REMARK 500 HIS B 73 -80.04 -111.98 REMARK 500 ASP B 94 -10.75 175.14 REMARK 500 ASP B 177 -155.32 -126.42 REMARK 500 ASP B 187 62.26 -162.88 REMARK 500 THR B 196 -6.93 -59.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 51G A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue COA A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue COA B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7CRM RELATED DB: PDB REMARK 900 7CRM CONTAINS THE SAME PROTEIN COMPLEXED WITH GENTAMICIN DBREF 7CSJ A 1 210 UNP P94968 AAC2_MYCS2 1 210 DBREF 7CSJ B 1 210 UNP P94968 AAC2_MYCS2 1 210 SEQRES 1 A 210 MET LEU THR GLN HIS VAL SER GLU ALA ARG THR ARG GLY SEQRES 2 A 210 ALA ILE HIS THR ALA ARG LEU ILE HIS THR SER ASP LEU SEQRES 3 A 210 ASP GLN GLU THR ARG ASP GLY ALA ARG ARG MET VAL ILE SEQRES 4 A 210 GLU ALA PHE ARG ASP PRO SER GLY ASP SER ASP PHE THR SEQRES 5 A 210 ASP ASP PHE THR ASP ASP ASP TRP ASP HIS ALA LEU GLY SEQRES 6 A 210 GLY MET HIS ALA LEU ILE SER HIS HIS GLY ALA LEU ILE SEQRES 7 A 210 ALA HIS GLY ALA VAL VAL GLN ARG ARG LEU MET TYR ARG SEQRES 8 A 210 GLY PRO ASP GLY ARG GLY HIS ALA LEU ARG CYS GLY TYR SEQRES 9 A 210 VAL GLU ALA VAL ALA VAL ARG GLU ASP ARG ARG GLY ASP SEQRES 10 A 210 GLY LEU GLY THR ALA VAL LEU ASP ALA LEU GLU GLN VAL SEQRES 11 A 210 ILE ARG GLY ALA TYR GLN ILE GLY ALA LEU SER ALA SER SEQRES 12 A 210 ASP ILE ALA ARG PRO MET TYR ILE ALA ARG GLY TRP LEU SEQRES 13 A 210 SER TRP GLU GLY PRO THR SER VAL LEU THR PRO THR GLU SEQRES 14 A 210 GLY ILE VAL ARG THR PRO GLU ASP ASP ARG SER LEU PHE SEQRES 15 A 210 VAL LEU PRO VAL ASP LEU PRO ASP GLY LEU GLU LEU ASP SEQRES 16 A 210 THR ALA ARG GLU ILE THR CYS ASP TRP ARG SER GLY ASP SEQRES 17 A 210 PRO TRP SEQRES 1 B 210 MET LEU THR GLN HIS VAL SER GLU ALA ARG THR ARG GLY SEQRES 2 B 210 ALA ILE HIS THR ALA ARG LEU ILE HIS THR SER ASP LEU SEQRES 3 B 210 ASP GLN GLU THR ARG ASP GLY ALA ARG ARG MET VAL ILE SEQRES 4 B 210 GLU ALA PHE ARG ASP PRO SER GLY ASP SER ASP PHE THR SEQRES 5 B 210 ASP ASP PHE THR ASP ASP ASP TRP ASP HIS ALA LEU GLY SEQRES 6 B 210 GLY MET HIS ALA LEU ILE SER HIS HIS GLY ALA LEU ILE SEQRES 7 B 210 ALA HIS GLY ALA VAL VAL GLN ARG ARG LEU MET TYR ARG SEQRES 8 B 210 GLY PRO ASP GLY ARG GLY HIS ALA LEU ARG CYS GLY TYR SEQRES 9 B 210 VAL GLU ALA VAL ALA VAL ARG GLU ASP ARG ARG GLY ASP SEQRES 10 B 210 GLY LEU GLY THR ALA VAL LEU ASP ALA LEU GLU GLN VAL SEQRES 11 B 210 ILE ARG GLY ALA TYR GLN ILE GLY ALA LEU SER ALA SER SEQRES 12 B 210 ASP ILE ALA ARG PRO MET TYR ILE ALA ARG GLY TRP LEU SEQRES 13 B 210 SER TRP GLU GLY PRO THR SER VAL LEU THR PRO THR GLU SEQRES 14 B 210 GLY ILE VAL ARG THR PRO GLU ASP ASP ARG SER LEU PHE SEQRES 15 B 210 VAL LEU PRO VAL ASP LEU PRO ASP GLY LEU GLU LEU ASP SEQRES 16 B 210 THR ALA ARG GLU ILE THR CYS ASP TRP ARG SER GLY ASP SEQRES 17 B 210 PRO TRP HET 51G A 301 33 HET COA A 302 48 HET COA B 501 48 HETNAM 51G GENTAMICIN C1 HETNAM COA COENZYME A HETSYN 51G (1S,2S,3R,4S,6R)-4,6-DIAMINO-3-({(2R,3R,6S)-3-AMINO-6- HETSYN 2 51G [(1R)-1-(METHYLAMINO)ETHYL]TETRAHYDRO-2H-PYRAN-2- HETSYN 3 51G YL}OXY)-2-HYDROX YCYCLOHEXYL 3-DEOXY-4-C-METHYL-3- HETSYN 4 51G (METHYLAMINO)-BETA-L-ARABINOPYRANOSIDE FORMUL 3 51G C21 H43 N5 O7 FORMUL 4 COA 2(C21 H36 N7 O16 P3 S) FORMUL 6 HOH *113(H2 O) HELIX 1 AA1 SER A 24 LEU A 26 5 3 HELIX 2 AA2 ASP A 27 ARG A 43 1 17 HELIX 3 AA3 THR A 56 HIS A 62 1 7 HELIX 4 AA4 GLU A 112 ARG A 115 5 4 HELIX 5 AA5 GLY A 118 TYR A 135 1 18 HELIX 6 AA6 ALA A 146 ARG A 153 1 8 HELIX 7 AA7 PRO A 175 ASP A 178 5 4 HELIX 8 AA8 SER B 24 LEU B 26 5 3 HELIX 9 AA9 ASP B 27 PHE B 42 1 16 HELIX 10 AB1 THR B 56 HIS B 62 1 7 HELIX 11 AB2 GLU B 112 ARG B 115 5 4 HELIX 12 AB3 GLY B 118 TYR B 135 1 18 HELIX 13 AB4 ALA B 146 ARG B 153 1 8 HELIX 14 AB5 LEU B 188 LEU B 192 5 5 SHEET 1 AA1 7 ARG A 19 HIS A 22 0 SHEET 2 AA1 7 MET A 67 HIS A 73 -1 O HIS A 68 N ILE A 21 SHEET 3 AA1 7 ALA A 76 TYR A 90 -1 O ILE A 78 N ILE A 71 SHEET 4 AA1 7 HIS A 98 VAL A 110 -1 O TYR A 104 N VAL A 84 SHEET 5 AA1 7 ILE A 137 SER A 141 1 O ILE A 137 N GLY A 103 SHEET 6 AA1 7 LEU A 181 PRO A 185 -1 O PHE A 182 N LEU A 140 SHEET 7 AA1 7 LEU A 156 SER A 157 -1 N LEU A 156 O VAL A 183 SHEET 1 AA2 6 ARG A 19 HIS A 22 0 SHEET 2 AA2 6 MET A 67 HIS A 73 -1 O HIS A 68 N ILE A 21 SHEET 3 AA2 6 ALA A 76 TYR A 90 -1 O ILE A 78 N ILE A 71 SHEET 4 AA2 6 ILE A 200 CYS A 202 -1 O THR A 201 N MET A 89 SHEET 5 AA2 6 THR A 162 LEU A 165 1 N LEU A 165 O CYS A 202 SHEET 6 AA2 6 ILE A 171 ARG A 173 -1 O VAL A 172 N VAL A 164 SHEET 1 AA3 7 ARG B 19 HIS B 22 0 SHEET 2 AA3 7 MET B 67 SER B 72 -1 O HIS B 68 N ILE B 21 SHEET 3 AA3 7 LEU B 77 ARG B 91 -1 O GLY B 81 N ALA B 69 SHEET 4 AA3 7 GLY B 97 VAL B 110 -1 O TYR B 104 N VAL B 84 SHEET 5 AA3 7 ILE B 137 SER B 143 1 O ALA B 139 N VAL B 105 SHEET 6 AA3 7 ARG B 179 PRO B 185 -1 O SER B 180 N ALA B 142 SHEET 7 AA3 7 LEU B 156 SER B 157 -1 N LEU B 156 O VAL B 183 SHEET 1 AA4 6 ARG B 19 HIS B 22 0 SHEET 2 AA4 6 MET B 67 SER B 72 -1 O HIS B 68 N ILE B 21 SHEET 3 AA4 6 LEU B 77 ARG B 91 -1 O GLY B 81 N ALA B 69 SHEET 4 AA4 6 ILE B 200 CYS B 202 -1 O THR B 201 N MET B 89 SHEET 5 AA4 6 THR B 162 LEU B 165 1 N SER B 163 O CYS B 202 SHEET 6 AA4 6 ILE B 171 ARG B 173 -1 O VAL B 172 N VAL B 164 SITE 1 AC1 17 PHE A 42 ASP A 53 ASP A 54 PHE A 55 SITE 2 AC1 17 ASP A 59 GLU A 106 SER A 141 ALA A 142 SITE 3 AC1 17 ASP A 144 GLU A 176 ASP A 177 TRP A 210 SITE 4 AC1 17 COA A 302 HOH A 411 HOH A 412 HOH A 426 SITE 5 AC1 17 HOH A 451 SITE 1 AC2 24 PHE A 42 VAL A 108 ALA A 109 VAL A 110 SITE 2 AC2 24 ARG A 115 GLY A 116 ASP A 117 GLY A 118 SITE 3 AC2 24 GLY A 120 THR A 121 SER A 143 ILE A 145 SITE 4 AC2 24 ALA A 146 PRO A 148 MET A 149 TYR A 150 SITE 5 AC2 24 51G A 301 HOH A 404 HOH A 410 HOH A 420 SITE 6 AC2 24 HOH A 434 HIS B 74 ARG B 96 HIS B 98 SITE 1 AC3 11 VAL B 108 ALA B 109 VAL B 110 ARG B 115 SITE 2 AC3 11 GLY B 116 ASP B 117 GLY B 118 LEU B 119 SITE 3 AC3 11 GLY B 120 THR B 121 MET B 149 CRYST1 54.486 60.212 116.955 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018353 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016608 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008550 0.00000